Hong X - Search Results

1

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

Vitolo U, Trněný M, Belada D, Burke JM, Carella AM, Chua N, Abrisqueta P, Demeter J, Flinn I, Hong X, Kim WS, Pinto A, Shi YK, Tatsumi Y, Oestergaard MZ, Wenger M, Fingerle-Rowson G, Catalani O, Nielsen T, Martelli M, Sehn LH. Vitolo U, et al. Among authors: hong x. J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10. J Clin Oncol. 2017. PMID: 28796588 Clinical Trial.

2

[Vinorelbine plus cisplatin in the treatment of advanced non-small cell lung cancer previously treated with taxane-based chemotherapy].

Zhang W, Cao JN, Yin JL, Hong XN, Xu LG. Zhang W, et al. Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):587-9. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14690569 Chinese.

3

[Experience of gemcitabine plus cisplatin chemotherapy in 52 patients with head and neck cancer].

Wang JL, Hong XN, Tang WY, Guo Y, Li J. Wang JL, et al. Zhonghua Zhong Liu Za Zhi. 2005 Sep;27(9):567-9. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438860 Chinese.

4

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J. Guo Y, et al. Among authors: hong x. Oral Oncol. 2008 Jan;44(1):23-30. doi: 10.1016/j.oraloncology.2006.11.020. Epub 2007 Feb 15. Oral Oncol. 2008. PMID: 17306611

5

[Prognostic factors of invasive non-Hodgkin's lymphoma].

Yu H, Hong XN, Li J, Peng LP, Ye L. Yu H, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):461-3. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974284 Chinese.

6

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.

Wang B, Li XQ, Ma X, Hong X, Lu H, Guo Y. Wang B, et al. Among authors: hong x. Am J Hematol. 2008 Oct;83(10):795-9. doi: 10.1002/ajh.21256. Am J Hematol. 2008. PMID: 18756548 Free article.

7

[Prognosis of primary non-Hodgkin's lymphoma of the breast].

Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J. Guo HY, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):200-2. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756936 Chinese.

8

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.

Liu X, Hong XN, Gu YJ, Wang BY, Luo ZG, Cao J. Liu X, et al. Among authors: hong xn. Leuk Lymphoma. 2008 Sep;49(9):1778-83. doi: 10.1080/10428190802270886. Leuk Lymphoma. 2008. PMID: 18798110

9

[Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].

Chen ZY, Zhou XY, Zhang TM, Hong XN, Yin JL, Hu XC, Shi DR. Chen ZY, et al. Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):183-8. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615255 Chinese.

10

Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.

Zhao XY, Hong XN, Cao JN, Leaw SJ, Guo Y, Li ZT, Chang JH. Zhao XY, et al. Med Oncol. 2011 Dec;28(4):1559-64. doi: 10.1007/s12032-010-9578-0. Epub 2010 May 28. Med Oncol. 2011. PMID: 20509008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,164 results

Search Page

Filters